Works matching IS 15588211 AND DT 2021 AND VI 16 AND IP 2
Results: 11
Enteropathy-Associated T cell Lymphoma.
- Published in:
- Current Hematologic Malignancy Reports, 2021, v. 16, n. 2, p. 140, doi. 10.1007/s11899-021-00634-4
- By:
- Publication type:
- Article
MRD Assessment in Multiple Myeloma: Progress and Challenges.
- Published in:
- Current Hematologic Malignancy Reports, 2021, v. 16, n. 2, p. 162, doi. 10.1007/s11899-021-00633-5
- By:
- Publication type:
- Article
Current Approach to Managing Patients with Newly Diagnosed High-Risk Multiple Myeloma.
- Published in:
- Current Hematologic Malignancy Reports, 2021, v. 16, n. 2, p. 148, doi. 10.1007/s11899-021-00631-7
- By:
- Publication type:
- Article
Goal of a "Good Death" in End-of-Life Care for Patients with Hematologic Malignancies—Are We Close?
- Published in:
- Current Hematologic Malignancy Reports, 2021, v. 16, n. 2, p. 117, doi. 10.1007/s11899-021-00629-1
- By:
- Publication type:
- Article
The Democratization of Scientific Conferences: Twitter in the Era of COVID-19 and Beyond.
- Published in:
- Current Hematologic Malignancy Reports, 2021, v. 16, n. 2, p. 132, doi. 10.1007/s11899-021-00620-w
- By:
- Publication type:
- Article
Evolution of Hematology Clinical Trial Adverse Event Reporting to Improve Care Delivery.
- Published in:
- Current Hematologic Malignancy Reports, 2021, v. 16, n. 2, p. 126, doi. 10.1007/s11899-021-00627-3
- By:
- Publication type:
- Article
Antibody-Based Treatment Approaches in Multiple Myeloma.
- Published in:
- Current Hematologic Malignancy Reports, 2021, v. 16, n. 2, p. 183, doi. 10.1007/s11899-021-00624-6
- By:
- Publication type:
- Article
Progress in the Management of Smoldering Multiple Myeloma.
- Published in:
- Current Hematologic Malignancy Reports, 2021, v. 16, n. 2, p. 172, doi. 10.1007/s11899-021-00623-7
- By:
- Publication type:
- Article
Chimeric Antigen Receptor–Modified T Cells and T Cell–Engaging Bispecific Antibodies: Different Tools for the Same Job.
- Published in:
- Current Hematologic Malignancy Reports, 2021, v. 16, n. 2, p. 218, doi. 10.1007/s11899-021-00628-2
- By:
- Publication type:
- Article
IDH Inhibitors in AML—Promise and Pitfalls.
- Published in:
- Current Hematologic Malignancy Reports, 2021, v. 16, n. 2, p. 207, doi. 10.1007/s11899-021-00619-3
- By:
- Publication type:
- Article
Novel Targeted Therapeutics in Acute Myeloid Leukemia: an Embarrassment of Riches.
- Published in:
- Current Hematologic Malignancy Reports, 2021, v. 16, n. 2, p. 192, doi. 10.1007/s11899-021-00621-9
- By:
- Publication type:
- Article